Home / Resources and Insights / Pave an Expressway to Phase I – Strategies that Accelerate...
Pave an Expressway to Phase I – Strategies that Accelerate Your Early Phase Programs
Less than 1 min read time
Topics:
The success of any new drug development starts in its early phase. The probability of success of a molecule increases dramatically after it passes first-in-human (FIH) and proof-of-concept (POC) studies.
Building a comprehensive understanding of the molecule is crucial to successful early phase development. API salt form and formulation selections are also key factors to successful phase I studies. Effective CMC strategies can significantly enhance the speed of early phase development and ultimately the chance for success in late-stage development. This webinar will present our experience in using the integrated API and drug product platform and formulation technologies to accelerate early-phase development to phase I and beyond.
Access on-demand webinars & videos
In this webinar, we will discuss the importance of phase-appropriate process development and various
Gated content
Please complete the form below to access this content.
Related Reading
Accelerating Novel Peptides into Clinical Trials with Integrated Partnership
Do you have peptide drug candidates in development?
Overcoming Key Challenges in PROTAC Drug Development
Pharmaceutical development of PROTAC (Proteolysis Targeting Chimeras) molecules presents significant challenges due to their complex molecular structures, leading to low...
